HGTY.NYSEHagerty, INC

Form 4: Hagerty Director Sells Over 33,000 Shares Under Pre-Arranged 10b5-1 Plan

Sentiment:

Insider Transaction Report


Hagerty, Inc. Director Robert I. Kauffman reported the sale of 33,230 shares of Class A Common Stock over three days in early June 2025, executed under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • Robert I. Kauffman, a Director of Hagerty, Inc. (HGTY), reported the sale of 33,230 shares of Class A Common Stock across three separate transactions.
  • On June 3, 2025, 7,681 shares were sold at a weighted average price of $9.92 per share.
  • On June 4, 2025, an additional 9,726 shares were sold at a weighted average price of $10.01 per share.
  • On June 5, 2025, 15,823 shares were sold at a weighted average price of $10.08 per share.
  • All reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kauffman on August 9, 2024.
  • Following these transactions, Mr. Kauffman beneficially owns 3,851,869 shares of Class A Common Stock indirectly through Aldel LLC, where he serves as manager with voting and investment discretion.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While insider selling can be viewed negatively, the execution under a pre-arranged 10b5-1 plan mitigates concerns about opportunistic trading and suggests personal financial planning rather than a lack of confidence in the company's fundamentals.

Positives

  • The sales were conducted under a Rule 10b5-1 trading plan, which indicates the transactions were pre-scheduled and not based on material non-public information, enhancing transparency and reducing concerns about opportunistic insider selling.

Negatives

  • Insider selling, even under a 10b5-1 plan, can sometimes be perceived by the market as a lack of confidence in the company's future prospects, although this is mitigated by the pre-planned nature of the sales.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Management Comments

  • The reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 9, 2024.
  • The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Industry Context

This Form 4 filing is specific to an insider transaction at Hagerty, Inc. and does not provide broader industry context or trends.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Insider Trading Policy/ComplianceThe sales were conducted under a Rule 10b5-1 trading plan, a mechanism used by insiders to sell securities in compliance with insider trading laws and company policies, demonstrating adherence to corporate governance best practices regarding insider transactions.08/09/2024Enhances transparency and reduces potential for accusations of trading on material non-public information, aligning with good corporate governance principles.

Stakeholder Impact

  • Shareholders: May view the insider selling with slight caution, but the 10b5-1 plan helps to alleviate concerns about the underlying health or prospects of the company. The volume of shares sold represents a small fraction of the director's total indirect holdings.

Key Dates

DateDescription
08/09/2024Date Rule 10b5-1 trading plan was adopted by the Reporting Person.
06/03/2025Transaction date for the sale of 7,681 shares of Class A Common Stock.
06/04/2025Transaction date for the sale of 9,726 shares of Class A Common Stock.
06/05/2025Transaction date for the sale of 15,823 shares of Class A Common Stock and filing date of the Form 4.

Recommendation

hold

Keywords

Hagerty, HGTY, Form 4, Insider Trading, Stock Sale, Beneficial Ownership, Robert I. Kauffman, Aldel LLC, 10b5-1 Plan, Director

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.